No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: A dutch multicenter study

International Journal of Gynecological Cancer

Volumn 21, Issue 4, 2011, Pages 647-653

  Geurts, Sandra M E ^a   Van Altena, Anne M ^a   De Vegt, Femmie ^a   Tjan Heijnen, Vivianne C G ^b   Massuger, Leon F A G ^a   Van Dijck, Jos A A M ^a   Verbeek, André L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Follow up; Ovarian cancer; Recurrence; Survival

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; EPITHELIAL OVARIAN CANCER; FALLOPIAN TUBE CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; OVARY CANCER; PERITONEUM CANCER; PRACTICE GUIDELINE; PRIMARY PERITONEAL CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CONTINUITY OF PATIENT CARE; DIAGNOSTIC TESTS, ROUTINE; EVIDENCE-BASED PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; NETHERLANDS; OFFICE VISITS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80051876326     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318212b87d     Document Type: Article

References (17)

1. Health Council of the Netherlands. Follow-up in Oncology: Identify Objectives, Substantiate Actions. Report No. 2007/10. The Hague, The Netherlands: Health Council of the Netherlands; 2007.
2. Kew FM, Galaal K, Manderville H. Patients' views of follow-up after treatment for gynaecological cancer. J Obstet Gynaecol. 2009;29:135-142.
3. Colombo N, Peiretti M, Parma G, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v23-v30.
4. Massuger LFAG, Kruitwagen RFPM, Coppens JMB, et al. Epithelial ovarian carcinoma: National guideline. Version 1. Available at: www.oncoline.nl: CRGO; 2009. Accessed February 21, 2011.
5. Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer. 2006;16:380-384.
6. Kerr-Wilson RHJ, McCrum A. Follow-up of patients with gynaecological cancer. Aust N Z J Obstet Gynaecol. 1995;35:298-299.
7. Barnhill D, O'Connor D, Farley J, et al. Clinical surveillance of gynecologic cancer patients. Gynecol Oncol. 1992;46:275-280.
8. Fleming LW. Playing the waiting game... the asymptomatic patient with recurrent ovarian cancer detected only by rising Ca125 levels. Scott Med J. 2001;46:81-83. (Pubitemid 32737433)
9. Rustin GJS, van der Burg MEL, Griffin CL, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV5/EORTC 55955 trials): a randomized trial. Lancet. 2010;376:1155-1163.
10. Gadducci A, Fuso L, Cosio S, et al. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer? A retrospective Italian multicentric study. Int J Gynecol Cancer. 2009;19:367-374.
11. Tanner EJ, Chi DS, Eisenhauer EL, et al. Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias? Gynecol Oncol. 2010;117: 336-340.
12. Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology. 2002;11:142-153. (Pubitemid 34256425)
13. Matulonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18:1183-1193.
14. Hodgkinson K, Butow P, Fuchs A, et al. Long-term survival from gynecologic cancer: Psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol. 2007;104:381-389. (Pubitemid 46135660)
15. Palli D, Russo A, Saieva C, et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. JAMA. 1999;281:1586. (Pubitemid 29211763)
16. Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848-855. (Pubitemid 46638835)
17. Cox A, Bull E, Cockle-Hearne J, et al. Nurse led telephone follow up in ovarian cancer: A psychosocial perspective. Eur J Oncol Nurs. 2008;12:412-417.